Diltiazem Hydrochloride
Product Images NDC 68258-6046

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 68258-6046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (4789cec5 Figure 01)

FDA Label Image

4789cec5-figure-02 (4789cec5 Figure 02)

FDA Label Image

4789cec5-figure-03 (4789cec5 Figure 03)

FDA Label Image

4789cec5-figure-04 (4789cec5 Figure 04)

FDA Label Image

4789cec5-figure-05 (4789cec5 Figure 05)

FDA Label Image

Ndc 68258-6046-xx (Ndc 68258 6046 Xx Actavis)

Ndc 68258-6046-xx (Ndc 68258 6046 Xx        Actavis)
This is a description of Diltiazem CD 180 mg extended-release capsules produced by Actavis Elizabeth LLC. The product comes in a dark green/aqua blue opaque capsule printed with R 2577 in white ink on both the cap and body. The bulk source NDC for this product is 00228-2577-50, and it should be dispensed in a tight/light resistant container. Patients should take one capsule orally as directed by their physician, being careful not to chew, crush, or divide the capsule. Dizziness, drowsiness, or headache may occur. The product should be stored at 77°F and kept out of children's reach. The manufacturer lot number is 0000. The pedigree number is 20807005. The capsules are packaged exclusively by Dispensing Solution VM in Santa Ana, CA, and have a revision date of 12/11.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.